| |
| |
|
| Insider
Information: |
Fishman Corey N. |
| Relationship: |
Director |
| City: |
Morristown |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
64,539 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$620,453 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,539 |
|
|
| Total
Value |
$620,453 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 13.8%
|
 -66.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durata Therapeutics, Inc. |
DRTX |
CFO&COO |
2014-11-17 |
0 |
2012-07-24 |
0 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Chief Executive Office... |
2023-11-20 |
54,449 |
2018-05-30 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2019-06-20 |
10,090 |
2018-06-20 |
0 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
Director |
2020-12-02 |
0 |
2020-04-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITRM |
Iterum Therapeutics Plc |
Chief Executive Officer |
• • – |
2023-11-20 |
4 |
B |
$1.59 |
$15,863 |
D/D |
10,000 |
54,449 |
2.81 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Executive Officer |
• • – |
2023-03-11 |
4 |
D |
$0.96 |
$5,456 |
D/D |
(5,683) |
44,449 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Executive Officer |
• • – |
2023-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
14,333 |
50,132 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
215,000 |
537,008 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
President & CEO |
• • – |
2021-01-26 |
4 |
S |
$1.73 |
$147,820 |
D/D |
(85,445) |
322,008 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
President & CEO |
• • – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
167,500 |
407,453 |
0 |
- |
|
| BSTC |
Biospecifics Technologies... |
Director |
– • – |
2020-12-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,018) |
0 |
0 |
- |
|
| BSTC |
Biospecifics Technologies... |
Director |
– • – |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,018 |
2,018 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2019-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,356 |
10,090 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
President & CEO |
• • – |
2018-08-17 |
4 |
B |
$8.73 |
$17,466 |
D/D |
2,000 |
239,953 |
2.81 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2018-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,734 |
5,734 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
President & CEO |
• • – |
2018-05-30 |
4 |
B |
$13.00 |
$39,000 |
D/D |
3,000 |
237,953 |
2.81 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
President & CEO |
• • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
38,900 |
234,953 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
CFO&COO |
• – – |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,941) |
0 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
CFO & COO |
• – – |
2012-07-24 |
5 |
B |
$9.00 |
$22,500 |
D/D |
2,500 |
24,941 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
COO & CFO |
• – – |
2012-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
22,441 |
22,441 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
